ArticleCell communication and signaling : CCS2026
SFPQ/S100A8 complex induces filaggrin deficiency via selective autophagy and JNK phosphorylation in atopic dermatitis.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAlthough atopic dermatitis (AD) is associated with a decrease of filaggrin levels, the underlying mechanisms are not clearly understood. Here, we aimed to investigate the pathogenic roles of the splicing factor proline- and glutamine-rich (SFPQ)/S100 calcium-binding protein A8 (S100A8) complex, a critical regulator inducing filaggrin deficiency in AD.
methodsThe formation of SFPQ/S100A8 complex was analyzed in the keratinocytes and skin tissues from patients with AD and 2,4-dinitrochlorobenzene (DNCB)-induced AD-like mice. The effects of leptomycin B, a CRM1 inhibitor, and rapamycin, a mTOR inhibitor were determined in DNCB-induced AD-like mice and the non-lesional and lesional primary keratinocytes of AD patients.
resultsThe relocation of SFPQ from the nucleus to the cytoplasm, elevated S100A8 levels, and SFPQ/S100A8 complex formation were proportional to filaggrin deficiency and AD severity in the keratinocytes of AD patients and AD-like mice. Interaction of the complex with filaggrin and c-Jun N-terminal kinase (JNK) accelerated filaggrin degradation via selective autophagy and filaggrin downregulation via JNK phosphorylation, respectively. The mechanistic target of rapamycin kinase (mTOR) and chromosomal region maintenance 1 (CRM1) facilitated the cytosolic export of SFPQ to form the complex in human keratinocytes. Administration of leptomycin B and rapamycin suppressed the decrease in filaggrin levels by inhibiting SFPQ/S100A8 complex formation in AD-like mice.
conclusionsThis study demonstrates that the formation of SFPQ/S100A8 complex is a critical process in AD progression, which provides key insights into the pathogenic mechanisms of AD. The elucidation of the SFPQ/S100A8 complex axis in AD pathogenesis can be leveraged to develop therapeutic drugs for AD treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.